Nechifor Ligia, O'Reilly Daniel, O'Loughlin John, Áinle Fionnuala Ní, Callion Naomi Mc, Zakharchenko Lyudmyla
Department of Paediatrics, The Rotunda Hospital, Dublin, Ireland.
Conway Sphere Research Group, School of Biomolecular and Biomedical Science, University College Dublin, Dublin, Ireland.
Res Pract Thromb Haemost. 2024 Nov 14;8(8):102622. doi: 10.1016/j.rpth.2024.102622. eCollection 2024 Nov.
Maternal thrombocytopenia during pregnancy is common. However, the relationship between maternal and neonatal thrombocytopenia is poorly understood.
We aimed to determine whether an association exists between platelet counts of neonates born to mothers with moderate-to-severe thrombocytopenia (<100 × 10/L) and neonatal platelet counts.
We identified records from 557 patients with moderate-to-severe thrombocytopenia (maternal platelet count <100 × 10/L) and the 338 associated newborn charts from 2018 to 2022 in a single large maternity center. Pregnant people with a platelet count of <100 × 10/L prior to delivery during present gestation were included. Any thrombocytopenia that occurred outside of pregnancy or in the postpartum period was excluded. A logistic regression was then generated to examine the association between maternal thrombocytopenia and neonatal thrombocytopenia. A receiver operating characteristic (ROC) curve was generated to assess accuracy of (i) lowest maternal platelet count and (ii) trimester of thrombocytopenia onset in predicting neonatal thrombocytopenia.
A total of 550 full blood count assessments were taken in neonates of pregnant people with thrombocytopenia. Sixteen neonates with clinically significant thrombocytopenia (platelet count <100 × 10/L) were identified. A binomial logistic regression was fitted that demonstrated limited association between lowest maternal platelet count and trimester of onset of maternal thrombocytopenia and the development of neonatal thrombocytopenia. An ROC curve was generated to determine the accuracy of maternal platelet count at identifying neonatal thrombocytopenia. The coordinates of the best platelet count threshold for this dataset were then derived from the ROC curve and determined that a threshold of 77.5 × 10/L maternal platelets offered the best accuracy.
Neonatal full blood count assessment based on maternal platelet counts of <100 × 10/L has a poor diagnostic yield with no statistically significant association in this cohort on logistic regression analysis. A lower threshold of 77.5 × 10/L may be of higher clinical utility and improve laboratory and clinical workflow.
孕期母体血小板减少很常见。然而,母体和新生儿血小板减少之间的关系尚不清楚。
我们旨在确定母亲患有中度至重度血小板减少(<100×10⁹/L)的新生儿血小板计数与新生儿血小板计数之间是否存在关联。
我们在一个大型产科中心识别了2018年至2022年期间557例中度至重度血小板减少患者(母体血小板计数<100×10⁹/L)的记录以及338份相关新生儿病历。纳入在本次妊娠分娩前血小板计数<100×10⁹/L的孕妇。排除孕期以外或产后发生的任何血小板减少情况。然后进行逻辑回归分析,以检验母体血小板减少与新生儿血小板减少之间的关联。绘制受试者工作特征(ROC)曲线,以评估(i)母体最低血小板计数和(ii)血小板减少开始的孕周在预测新生儿血小板减少方面的准确性。
对血小板减少孕妇的新生儿共进行了550次全血细胞计数评估。确定了16例具有临床意义的血小板减少新生儿(血小板计数<100×10⁹/L)。进行了二项逻辑回归分析,结果显示母体最低血小板计数和母体血小板减少开始的孕周与新生儿血小板减少的发生之间关联有限。绘制ROC曲线以确定母体血小板计数在识别新生儿血小板减少方面的准确性。然后从ROC曲线得出该数据集的最佳血小板计数阈值坐标,确定母体血小板阈值为77.5×10⁹/L时准确性最佳。
基于母体血小板计数<100×10⁹/L对新生儿进行全血细胞计数评估的诊断效率较低,在该队列的逻辑回归分析中无统计学意义的关联。较低阈值77.5×10⁹/L可能具有更高的临床实用性,并改善实验室和临床工作流程。